Tonix Pharmaceuticals Advances Fibromyalgia Treatment, Reports Q1 Financial Results
Tonix Pharmaceuticals is poised for potential FDA approval of a groundbreaking fibromyalgia treatment in August, marking the first new drug class for the condition in over 15 years while demonstrating strategic progress across its pharmaceutical pipeline.
Read the full story